Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors
Clinical trial NCT03945253 · COMPLETED
Trial details
- NCT number
- NCT03945253
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2020-06-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.